Interpretation and management of hepatic abnormalities in pregnancy

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 11, 2013, Pages 1392-1398

  Kia, Leila ^a   Rinella, Mary E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Acute Fatty Liver of Pregnancy; HELLP Syndrome; Intrahepatic Cholestasis of Pregnancy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BILIRUBIN; CHOLESTEROL; COLESTYRAMINE; DEXAMETHASONE; ESTROGEN; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME; MAGNESIUM SULFATE; PHENOBARBITAL; S ADENOSYLMETHIONINE; SELENIUM; THIAMINE; URSODEOXYCHOLIC ACID;

ABNORMAL LABORATORY RESULT; ARTICLE; DEHYDRATION; DOPPLER FLOWMETRY; FEMALE; FETUS MORTALITY; FIRST TRIMESTER PREGNANCY; GALLSTONE FORMATION; HELLP SYNDROME; HEPATITIS A; HEPATITIS B; HUMAN; HYPEREMESIS GRAVIDARUM; INTRAHEPATIC CHOLESTASIS; LIVER DISEASE; LIVER FATTY DEGENERATION; MATERNAL AGE; MATERNAL MORBIDITY; MATERNAL MORTALITY; MEDICAL HISTORY; MULTIPARA; NUTRITIONAL DEFICIENCY; PERINATAL MORBIDITY; PREGNANCY; PREGNANCY TOXEMIA; PROPHYLAXIS; SEIZURE; THIRD TRIMESTER PREGNANCY; VITAMIN SUPPLEMENTATION; WERNICKE ENCEPHALOPATHY;

ACUTE FATTY LIVER OF PREGNANCY; AFLOP; HCV; HELLP; HELLP SYNDROME; HEPATITIS C VIRUS; HG; HYPEREMESIS GRAVIDARUM; ICP; INTRAHEPATIC CHOLESTASIS OF PREGNANCY; SBA; SERUM BILE ACID; SYNDROME OF HEMOLYSIS, INCREASED LIVER ENZYMES, AND LOW PLATELETS; UDCA; URSODEOXYCHOLIC ACID;

DELIVERY, OBSTETRIC; EARLY DIAGNOSIS; FEMALE; HUMANS; LIVER DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84885867742     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.05.016     Document Type: Article

References (77)

1. Mufti A.R., Reau N. Liver disease in pregnancy. Clinics in liver disease 2012, 16:247-269.
2. Robson S.C., Mutch E., Boys R.J., et al. Apparent liver blood flow during pregnancy: a serial study using indocyanine green clearance. Br J Obstetr Gynaecol 1990, 97:720-724.
3. Munnell E.W., Taylor H.C. Liver blood flow in pregnancy-hepatic vein catheterization. JClin Invest 1947, 26:952-956.
4. Egan N., Bartels A., Khashan A.S., et al. Reference standard for serum bile acids in pregnancy. BJOG 2012, 119:493-498.
5. Elinav E., Ben-Dov I.Z., Shapira Y., et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 2006, 130:1129-1134.
6. Pastorek J.G., Miller J.M., Summers P.R. The effect of hepatitis B antigenemia on pregnancy outcome. Am J Obstetr Gynecol 1988, 158:486-489.
7. Burk R.D., Hwang L.Y., Ho G.Y., et al. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. JInfect Dis 1994, 170:1418-1423.
8. Pan C.Q., Duan Z.P., Bhamidimarri K.R., et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol 2012, 10:452-459.
9. Ozaslan E., Yilmaz R., Simsek H., et al. Interferon therapy for acute hepatitis C during pregnancy. Ann Pharmacother 2002, 36:1715-1718.
10. Gonzalez F., Medam-Djomo M.A., Lucidarme D., et al. Acute hepatitis C during the third trimester of pregnancy. Gastroenterol Clin Biol 2006, 30:786-789.
11. Gervais A., Bacq Y., Bernuau J., et al. Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. JHepatol 2000, 32:293-299.
12. Conte D., Fraquelli M., Prati D., et al. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000, 31:751-755.
13. Khuroo M.S., Teli M.R., Skidmore S., et al. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981, 70:252-255.
14. Kumar S., Subhadra S., Singh B., et al. Hepatitis E virus: the current scenario. Int J Infect Dis 2013, 17:e228-e233.
15. Tozzi di Angelo I., Prochazka V., Holinka M., et al. Endosonography versus endoscopic retrograde cholangiopancreatography in diagnosing extrahepatic biliary obstruction. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011, 155:339-346.
16. Bacq Y. Liver diseases unique to pregnancy: a 2010 update. Clin Res Hepatol Gastroenterol 2011, 35:182-193.
17. Pan C., Perumalswami P.V. Pregnancy-related liver diseases. Clin Liver Dis 2011, 15:199-208.
18. Paauw J.D., Bierling S., Cook C.R., et al. Hyperemesis gravidarum and fetal outcome. JPEN J Parenter Enteral Nutr 2005, 29:93-96.
19. Fell D.B., Dodds L., Joseph K.S., et al. Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy. Obstet Gynecol 2006, 107:277-284.
20. Morali G.A., Braverman D.Z. Abnormal liver enzymes and ketonuria in hyperemesis gravidarum. A retrospective review of 80 patients. JClin Gastroenterol 1990, 12:303-305.
21. Matsubara S., Kuwata T., Kamozawa C., et al. Connection between hyperemesis gravidarum, jaundice or liver dysfunction, and biliary sludge. JObstet Gynaecol Res 2012, 38:446-448.
22. Bottomley C., Bourne T. Management strategies for hyperemesis. Best Pract Res Clin Obstet Gynaecol 2009, 23:549-564.
23. Lammert F., Marschall H.U., Glantz A., et al. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. JHepatol 2000, 33:1012-1021.
24. Reyes H., Baez M.E., Gonzalez M.C., et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. JHepatol 2000, 32:542-549.
25. Berg B., Helm G., Petersohn L., et al. Cholestasis of pregnancy. Clinical and laboratory studies. Acta Obstet Gynecol Scand 1986, 65:107-113.
26. Reyes H. Sex hormones and bile acids in intrahepatic cholestasis of pregnancy. Hepatology 2008, 47:376-379.
27. Reyes H., Gonzalez M.C., Ribalta J., et al. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med 1978, 88:487-493.
28. Glantz A., Marschall H.U., Mattsson L.A. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004, 40:467-474.
29. Abu-Hayyeh S., Papacleovoulou G., Williamson C. Nuclear receptors, bile acids and cholesterol homeostasis series-bile acids and pregnancy. Mol Cell Endocrinol 2013, 368:120-128.
30. Dixon P.H., van Mil S.W., Chambers J., et al. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 2009, 58:537-544.
31. Bacq Y., Gendrot C., Perrotin F., et al. ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy. JMed Genet 2009, 46:711-715.
32. Keitel V., Vogt C., Haussinger D., et al. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. Gastroenterology 2006, 131:624-629.
33. Wang H., Yan Z., Dong M., et al. Alteration in placental expression of bile acids transporters OATP1A2, OATP1B1, OATP1B3 in intrahepatic cholestasis of pregnancy. Arch Gynecol Obstetr 2012, 285:1535-1540.
34. Williamson C., Hems L.M., Goulis D.G., et al. Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG 2004, 111:676-681.
35. Reyes H., Ribalta J., Gonzalez M.C., et al. Sulfobromophthalein clearance tests before and after ethinyl estradiol administration, in women and men with familial history of intrahepatic cholestasis of pregnancy. Gastroenterology 1981, 81:226-231.
36. Meng L.J., Reyes H., Axelson M., et al. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy. Hepatology 1997, 26:1573-1579.
37. Abu-Hayyeh S., Papacleovoulou G., Lovgren-Sandblom A., et al. Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype. Hepatology 2013, 57:716-726.
38. Imam M.H., Gossard A.A., Sinakos E., et al. Pathogenesis and management of pruritus in cholestatic liver disease. JGastroenterol Hepatol 2012, 27:1150-1158.
39. Ropponen A., Sund R., Riikonen S., et al. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 2006, 43:723-728.
40. Pata O., Vardareli E., Ozcan A., et al. Intrahepatic cholestasis of pregnancy: correlation of preterm delivery with bile acids. Turk J Gastroenterol 2011, 22:602-605.
41. Bacq Y., Sapey T., Brechot M.C., et al. Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 1997, 26:358-364.
42. Alsulyman O.M., Ouzounian J.G., Ames-Castro M., et al. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol 1996, 175:957-960.
43. Rioseco A.J., Ivankovic M.B., Manzur A., et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994, 170:890-895.
44. Fisk N.M., Bye W.B., Storey G.N. Maternal features of obstetric cholestasis: 20 years experience at King George V Hospital. Aust N Z J Obstet Gynaecol 1988, 28:172-176.
45. Laatikainen T., Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet 1984, 22:91-94.
46. Geenes V., Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009, 15:2049-2066.
47. Binder T., Salaj P., Zima T., et al. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. JPerinat Med 2006, 34:383-391.
48. Glantz A., Marschall H.U., Lammert F., et al. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005, 42:1399-1405.
49. Chappell L.C., Gurung V., Seed P.T., et al. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ 2012, 344:e3799.
50. Ribalta J., Reyes H., Gonzalez M.C., et al. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results. Hepatology 1991, 13:1084-1089.
51. Zapata R., Sandoval L., Palma J., et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience. Liver Int 2005, 25:548-554.
52. Bacq Y., Sentilhes L., Reyes H.B., et al. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology 2012, 143:1492-1501.
53. Glantz A., Reilly S.J., Benthin L., et al. Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. Hepatology 2008, 47:544-551.
54. Geenes V.L., Lim Y.H., Bowman N., et al. Aplacental phenotype for intrahepatic cholestasis of pregnancy. Placenta 2011, 32:1026-1032.
55. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
56. Catov J.M., Ness R.B., Kip K.E., et al. Risk of early or severe pre-eclampsia related to pre-existing conditions. Int J Epidemiol 2007, 36:412-419.
57. Sibai B.M. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol 2011, 205:191-198.
58. Barton J.R., Sibai B.M. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol 2004, 31:807-833. vii.
59. Joshi D., James A., Quaglia A., et al. Liver disease in pregnancy. Lancet 2010, 375:594-605.
60. Magann E.F., Martin J.N. Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol 1999, 42:532-550.
61. Abramovici D., Friedman S.A., Mercer B.M., et al. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?. Am J Obstet Gynecol 1999, 180:221-225.
62. Woudstra D.M., Chandra S., Hofmeyr G.J., et al. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev 2010, 9:CD008148.
63. Burwick R.M., Feinberg B.B. Eculizumab for the treatment of preeclampsia/HELLP syndrome. Placenta 2013, 34:201-203.
64. Pavlis T., Aloizos S., Aravosita P., et al. Diagnosis and surgical management of spontaneous hepatic rupture associated with HELLP syndrome. JSurg Educ 2009, 66:163-167.
65. Wicke C., Pereira P.L., Neeser E., et al. Subcapsular liver hematoma inHELLP syndrome: evaluation of diagnostic and therapeutic options-a unicenter study. Am J Obstet Gynecol 2004, 190:106-112.
66. Smith L.G., Moise K.J., Dildy G.A., et al. Spontaneous rupture of liver during pregnancy: current therapy. Obstet Gynecol 1991, 77:171-175.
67. Castro M.A., Fassett M.J., Reynolds T.B., et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol 1999, 181:389-395.
68. Knight M., Nelson-Piercy C., Kurinczuk J.J., et al. Aprospective national study of acute fatty liver of pregnancy in the UK. Gut 2008, 57:951-956.
69. Reyes H., Sandoval L., Wainstein A., et al. Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients. Gut 1994, 35:101-106.
70. Ibdah J.A., Bennett M.J., Rinaldo P., et al. Afetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. NEngl J Med 1999, 340:1723-1731.
71. Natarajan S.K., Thangaraj K.R., Eapen C.E., et al. Liver injury in acute fatty liver of pregnancy: possible link to placental mitochondrial dysfunction and oxidative stress. Hepatology 2010, 51:191-200.
72. Bacq Y., Constans T., Body G., et al. [Acute fatty liver of pregnancy]. JGynecol Obstet Biol Reprod 1986, 15:851-861.
73. Goel A., Ramakrishna B., Zachariah U., et al. How accurate are the Swansea criteria to diagnose acute fatty liver of pregnancy in predicting hepatic microvesicular steatosis?. Gut 2011, 60:138-139. author reply 139-140.
74. Ch'ng C.L., Morgan M., Hainsworth I., et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002, 51:876-880.
75. Vigil-de Gracia P., Montufar-Rueda C. Acute fatty liver of pregnancy: diagnosis, treatment, and outcome based on 35 consecutive cases. JMatern Fetal Neonatal Med 2011, 24:1143-1146.
76. Yang Z., Yamada J., Zhao Y., et al. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. JAMA 2002, 288:2163-2166.
77. Fesenmeier M.F., Coppage K.H., Lambers D.S., et al. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol 2005, 192:1416-1419.